Pathophysiology of Cardiovascular Complications in COVID-19

Vladimir Petrovic1, Dina Radenkovic2, Goran Radenkovic1

  • 1Department of Histology and Embryology, Faculty of Medicine, University of Nis, Nis, Serbia.

Frontiers in Physiology
|November 9, 2020
PubMed

Insights

Patients with cardiovascular disease (CVD) face higher COVID-19 mortality. COVID-19 can cause new heart problems, especially in older adults, necessitating clear clinical protocols for managing these cardiovascular complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Patients with pre-existing cardiovascular disease (CVD) exhibit increased severity and mortality from COVID-19.
  • COVID-19 is linked to new-onset cardiovascular complications, particularly in older individuals and those with chronic cardiometabolic conditions.
  • The SARS-CoV-2 virus can induce both acute cardiac injury and chronic cardiovascular damage.

Purpose of the Study:

  • To review the literature on COVID-19 and cardiovascular complications.
  • To discuss the pathophysiology and molecular mechanisms underlying these complications.
  • To identify potential novel therapeutic targets for cardiovascular complications in COVID-19 patients.

Main Methods:

  • Literature review focusing on cardiovascular complications in COVID-19.
  • Analysis of molecular pathways including cytokine release syndrome, RAAS dysregulation, plaque destabilization, and coagulation disorders.
  • Review of pediatric inflammatory multisystem syndrome associated with COVID-19.

Main Results:

  • Cardiovascular disease (CVD) is a major comorbidity in severe COVID-19 cases, often leading to mortality.
  • COVID-19 can trigger various cardiovascular issues, including acute injury and chronic damage.
  • Pediatric inflammatory multisystem syndrome is a significant cause of cardiovascular complications in children post-COVID-19.

Conclusions:

  • Understanding the pathophysiology of COVID-19-related cardiovascular complications is crucial for identifying treatment targets.
  • Clear clinical and follow-up protocols are needed for patients with COVID-19 and CVD.
  • Identifying and managing risk factors for cardiovascular complications in COVID-19 patients is essential.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
198
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
226
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
208
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
231